JM2 Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
2,815
-644
-19% -$52K 0.15% 114
2026
Q1
$300K Sell
3,459
-160
-4% -$15.3K 0.25% 92
2025
Q4
$348K Buy
+3,619
New +$352K 0.28% 83

Other funds holding MDT

JM2 Capital's MDT Position: Q2 2026 in Review

JM2 Capital reduced its Medtronic (MDT) stake by 19% in Q2 2026, selling an estimated $52K and leaving 2,815 shares worth $220K. The position accounts for 0.15% of the portfolio, ranked #114.

JM2 Capital first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $348K in Q4 2025. 1,239 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • JM2 Capital held 2,815 shares of Medtronic worth $220K as of Q2 2026.
  • JM2 Capital sold 644 Medtronic shares in Q2 2026, an estimated $52K.
  • Medtronic made up 0.15% of JM2 Capital's portfolio in Q2 2026, its #114 holding.
  • JM2 Capital first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • JM2 Capital's Medtronic position peaked at $348K in Q4 2025.
  • 1,239 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on JM2 Capital's 13F filing for Q2 2026, filed 22 Jul 2026.